Sreekumar U. Aiswarya

Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy

Nair Hariprasad Haritha, Akbar Nawab, Vinod Vijayakurup et al. · Frontiers in Oncology · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacology +16

Unlocking nature’s pharmacy: an in-depth exploration of phytochemicals as potential sources of anti-cancer and anti-inflammatory molecules

Shifana Chembothumparambil Sadiq, M. Joy, Sreekumar U. Aiswarya et al. · Exploration of Drug Science · 2024 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma

Mundanattu Swetha, Chenicheri K. Keerthana, Tennyson P. Rayginia et al. · Pharmaceuticals · 2022 · 13 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential

Sreekumar U. Aiswarya, Gowda Vikas, Nair Hariprasad Haritha et al. · Frontiers in Oncology · 2022 · 13 citations · Full text

Medicine, Oncology, Pharmacology +11

Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis

Anwar Shabna, Jayesh Antony, Vinod Vijayakurup et al. · Cellular and Molecular Life Sciences · 2022 · 13 citations · Full text

Medicine, Oncology, Pharmacology +14